ArticleClinical drug investigation2018

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.

Vladimir M Moiseyenko et al.PubMed ↗Publisher ↗

No numbers read from the abstract.